HOME
ABOUT
TEAM
INVESTORS
CONTACT
More
A NEW PARADIGM FOR VT ABLATION
CardioSolv™ is an early stage company developing new strategies to improve the treatment of patients with Ventricular Tachycardia (VT), a life-threatening arrhythmia.